FIELD: medicine.
SUBSTANCE: extremity ischemia is modelled by removing a portion of a great vessel, including with simultaneous additional modelling of nitrogen oxide (NO) deficiency by intraperitoneal introduction of a NO synthesis blocker N-nitro-L-arginine of methyl ester (L-NAME) 25 mg/kg daily for 7 days. In both cases, the ischemia is corrected by subcutaneous introduction of recombinant erythropoein 50 IU/kg for the first, third and fifth days of experiment.
EFFECT: effective ischemia treatment in experiment ensured by improved extremity microcirculation.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH SILNEDAFIL INCLUDING IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2012 |
|
RU2497203C2 |
METHOD FOR RECOMBINANT ERYTHROPOIETIN CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2409873C1 |
METHOD FOR PREVENTION OF ISCHEMIA OF RETINA EXPERIMENTALLY | 2013 |
|
RU2539630C1 |
ISCHEMIA CORRECTION METHOD | 2010 |
|
RU2438192C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY RECOMBINANT ERYTHROPOIETIN IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2462766C1 |
METHOD FOR PREVENTION OF ISCHEMIA OF RETINA WITH ERYTHROPOETIN EXPERIMENTALLY | 2013 |
|
RU2539629C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXTREMITY ISCHEMIA | 2011 |
|
RU2466463C2 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF LIMB'S ISCHEMIA | 2006 |
|
RU2302239C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH MINOXIDIL | 2012 |
|
RU2497200C1 |
METHOD FOR PLACENTAL MICROCIRCULATION CORRECTION BY RECOMBINANT ERYTHROPOIETIN IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2466462C1 |
Authors
Dates
2011-08-10—Published
2010-03-29—Filed